Differential uptake of 68Ga-PSMA-HBED-CC (PSMA-11) in low-grade versus high-grade gliomas in treatment-naive patients P Verma, G Malhotra, A Goel, S Rakshit, A Chandak, R Chedda, ... Clinical nuclear medicine 44 (5), e318-e322, 2019 | 47 | 2019 |
Initial clinical evaluation of indigenous 90Y-DOTATATE in sequential duo-PRRT approach (177Lu-DOTATATE and 90Y-DOTATATE) in neuroendocrine tumors with large bulky disease … R Parghane, A Mitra, T Bannore, S Rakshit, S Banerjee, S Basu World Journal of Nuclear Medicine 20 (01), 73-81, 2021 | 8 | 2021 |
Development of a phantom and assessment of 141Ce as a surrogate radionuclide for flood field uniformity testing of gamma cameras SK Saxena, Y Kumar, B Malpani, S Rakshit, A Dash Applied Radiation and Isotopes 112, 115-121, 2016 | 5 | 2016 |
Therapeutic Multidose Preparation of a Ready-to-Use 177Lu-PSMA-617 Using Carrier Added Lutetium-177 in a Hospital Radiopharmacy and Its Clinical Efficacy A Chakraborty, A Mitra, M Tawate, S Sahoo, S Lad, S Rakshit, S Gaikwad, ... Cancer Biotherapy & Radiopharmaceuticals 36 (8), 682-692, 2021 | 4 | 2021 |
Remarkably enhanced upconversion luminescence in Na+ codoped spinel nanoparticles for photothermal cancer therapy and SPECT imaging A Balhara, SK Gupta, N Aggarwal, S Srivastava, JJ Panda, S Patra, ... Materials Advances 4 (21), 5338-5352, 2023 | 3 | 2023 |
Clinical Dose Preparation of [177Lu]Lu-DOTA-Pertuzumab Using Medium Specific Activity [177Lu]LuCl3 for Radioimmunotherapy of Breast and Epithelial … SR Menon, A Mitra, A Chakraborty, M Tawate, S Sahu, S Rakshit, ... Cancer Biotherapy & Radiopharmaceuticals 37 (5), 384-402, 2022 | 3 | 2022 |
Correlation of lesional uptake parameters and ratios with miPSMA score and estimating normal physiologic concentration: an exploratory analysis in metastatic castration … A Kalshetty, B Menon, S Rakshit, A Bhattacharjee, S Basu Journal of nuclear medicine technology 49 (3), 235-240, 2021 | 3 | 2021 |
Diagnosis of pathological conditions in laboratory animals by using advance nuclear medicine imaging techniques Y Pawar, U Bhartiya, S Rakshit, S Nandy, N Lakshminarayanan, ... Indian Association of Veterinary Pathologists 43 (2), 109-114, 2019 | 3 | 2019 |
Chelator-free radiolabeling with theoretical insights and preclinical evaluation of citrate-functionalized hydroxyapatite nanospheres for potential use as radionanomedicine S Patra, S Kancharlapalli, A Chakraborty, K Singh, C Kumar, A Guleria, ... Industrial & Engineering Chemistry Research 62 (7), 3194-3205, 2023 | 2 | 2023 |
Sequential Duo–Peptide Receptor Radionuclide Therapy With Indigenous 90Y-DOTATATE and 177Lu-DOTATATE in Large-Volume Neuroendocrine Tumors: Posttherapy Bremsstrahlung and PET … RV Parghane, A Mitra, T Upadhye, S Rakshit, S Banerjee, S Basu Clinical Nuclear Medicine 45 (9), 714-715, 2020 | 2 | 2020 |
Evaluation of Pendrin Expression Using Nuclear Imaging Modalities and Immunohistochemistry in Animal Thyroid Cancer Model CS Gholve, Y Shete, S Rakshit, S Kulkarni Indian Journal of Nuclear Medicine 38 (4), 328-333, 2023 | 1 | 2023 |
Synthesis and 177Lu Labeling of the First Retro Analog of the HER2-Targeting A9 Peptide: A Superior Variant AK Sharma, R Sharma, A Das, A Chakraborty, S Rakshit, HD Sarma, ... Bioconjugate Chemistry 34 (9), 1576-1584, 2023 | 1 | 2023 |
[99mTc] Tc-HYNIC-RM2: A potential SPECT probe targeting GRPR expression in prostate cancers K Vats, A Chakraborty, S Rakshit, A Damle, HD Sarma, D Satpati Nuclear Medicine and Biology 118, 108331, 2023 | 1 | 2023 |
68Ga-Labeled Trastuzumab Fragments for ImmunoPET Imaging of Human Epidermal Growth Factor Receptor 2 Expression in Solid Cancers SK Suman, A Mukherjee, U Pandey, A Chakraborty, S Rakshit, M Tawate, ... Cancer Biotherapy & Radiopharmaceuticals 38 (1), 38-50, 2023 | 1 | 2023 |
Radiochemical formulation of 177Lu-DOTA-trastuzumab: using low specific activity 177LuCl3 M Tawate, A Mitra, A Chakraborty, S Lad, S Gaikwad, S Sahu, S Rakshit, ... Nuclear Medicine and Biology 108, S146, 2022 | 1 | 2022 |
Use case of no code machine learning tools for medical image classification. A Kalshetty, S Rakshit | 1 | 2021 |
Preclinical evaluation of a multi-dose formulation of Lu-177-DOTA-prostate specific membrane antigen-617 for clinical translation in metastatic castration resistant prostate … SK Sahu, A Mitra, A Chakrabotry, HH Shimpi, S Lad, M Tawate, ... Indian Journal of Nuclear Medicine 34 (5, suppl. 1), 95, 2019 | 1 | 2019 |
Radiochemical synthesis and pre-clinical evaluation of [68Ga]Ga-FAPI-4 formulated using in-house developed FAPI-4 kit N Sakhare, A Mitra, A Chakraborty, S Sahu, L Ram, S Rakshit, S Kumar, ... Journal of Radioanalytical and Nuclear Chemistry, 1-11, 2024 | | 2024 |
Expanding a peptide-covalent probe hybrid for PET imaging of S. aureus driven focal infections J Bhatt Mitra, S Chatterjee, A Kumar, E Khatoon, A Chandak, S Rakshit, ... EJNMMI Radiopharmacy and Chemistry 9 (1), 25, 2024 | | 2024 |
Nuclear Localization Signal Enhances the Targeting and Therapeutic Efficacy of a Porphyrin-Based Molecular Cargo: A Systemic In Vitro and Ex Vivo Evaluation N Kumar, AK Sharma, M Guleria, SB Shelar, A Chakraborty, S Rakshit, ... Molecular Pharmaceutics, 2024 | | 2024 |